BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30965384)

  • 1. Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomized controlled trial.
    Dieng M; Morton RL; Costa DSJ; Butow PN; Menzies SW; Lo S; Mann GJ; Cust AE; Kasparian NA
    Br J Dermatol; 2020 Apr; 182(4):860-868. PubMed ID: 30965384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial.
    Dieng M; Butow PN; Costa DS; Morton RL; Menzies SW; Mireskandari S; Tesson S; Mann GJ; Cust AE; Kasparian NA
    J Clin Oncol; 2016 Dec; 34(36):4405-4414. PubMed ID: 27998215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoeducational intervention for people at high risk of developing another melanoma: a pilot randomised controlled trial.
    Dieng M; Kasparian NA; Mireskandari S; Butow P; Costa D; Morton R; Mann G; Menzies S; Cust A
    BMJ Open; 2017 Oct; 7(10):e015195. PubMed ID: 29018064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the 'Active Ingredients' of an Effective Psychological Intervention to Reduce Fear of Cancer Recurrence: A Process Evaluation.
    Kan JM; Dieng M; Butow PN; Mireskandari S; Tesson S; Menzies SW; Costa DSJ; Morton RL; Mann GJ; Cust AE; Kasparian NA
    Front Psychol; 2021; 12():661190. PubMed ID: 34163405
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
    Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
    JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma.
    Dieng M; Cust AE; Kasparian NA; Butow P; Costa DS; Menzies SW; Mann GJ; Morton RL
    BMJ Open; 2016 Oct; 6(10):e012153. PubMed ID: 27855094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma.
    Dieng M; Khanna N; Kasparian NA; Costa DSJ; Butow PN; Menzies SW; Mann GJ; Cust AE; Morton RL
    Appl Health Econ Health Policy; 2019 Oct; 17(5):669-681. PubMed ID: 31228015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.
    Johns SA; Stutz PV; Talib TL; Cohee AA; Beck-Coon KA; Brown LF; Wilhelm LR; Monahan PO; LaPradd ML; Champion VL; Miller KD; Giesler RB
    Cancer; 2020 Jan; 126(1):211-218. PubMed ID: 31539169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0-II) melanoma.
    Thompson JR; Smith AL; Lo SN; Kasparian NA; Saw RP; Dieng M; Seaman L; Martin LK; Guitera P; Milne D; Schmid H; Cust AE; Bartula I
    BMJ Open; 2022 Mar; 12(3):e054337. PubMed ID: 35241467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
    Maheu C; Lebel S; Courbasson C; Lefebvre M; Singh M; Bernstein LJ; Muraca L; Benea A; Jolicoeur L; Harris C; Ramanakumar AV; Ferguson S; Sidani S
    BMC Cancer; 2016 Apr; 16():291. PubMed ID: 27112319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol of an implementation study of a clinician intervention to reduce fear of recurrence in cancer survivors (CIFeR_2 implementation study).
    Liu J; Serafimovska A; He S; Butow P; Shaw J; McHardy CJ; Harris G; Butt Z; Beith J
    BMC Med Educ; 2023 May; 23(1):312. PubMed ID: 37147706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer.
    van Helmondt SJ; van der Lee ML; de Vries J
    BMC Cancer; 2016 Jul; 16():527. PubMed ID: 27455846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel clinician-delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2).
    Liu J; He S; Butow P; Shaw J; McHardy CJ; Harris G; Serafimovska A; Butt Z; Beith J
    Psychooncology; 2023 Dec; 32(12):1930-1938. PubMed ID: 37955600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBT-based Online Self-help Training to Reduce Fear and Distress After Cancer (CAREST Randomized Trial): 24 Months Follow-up Using Latent Growth Models and Latent Class Analysis.
    van Helmondt SJ; Lodder P; van Woezik R; de Vries J; van der Lee ML
    Ann Behav Med; 2023 Aug; 57(9):787-799. PubMed ID: 37078920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry.
    van de Wal M; van de Poll-Franse L; Prins J; Gielissen M
    Psychooncology; 2016 Jul; 25(7):772-8. PubMed ID: 26464337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer.
    Jeppesen MM; Jensen PT; Hansen DG; Christensen RD; Mogensen O
    BJOG; 2018 Dec; 125(13):1705-1714. PubMed ID: 29978593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of an online mindfulness-based program for patients with melanoma: study protocol for a randomised controlled trial.
    Russell L; Ugalde A; Milne D; Krishnasamy M; O Seung Chul E; Austin DW; Chambers R; Orellana L; Livingston PM
    Trials; 2018 Apr; 19(1):223. PubMed ID: 29653555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.
    Lincoln NB; Bradshaw LE; Constantinescu CS; Day F; Drummond AE; Fitzsimmons D; Harris S; Montgomery AA; das Nair R
    Health Technol Assess; 2020 Jan; 24(4):1-182. PubMed ID: 31934845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence.
    Butow PN; Turner J; Gilchrist J; Sharpe L; Smith AB; Fardell JE; Tesson S; O'Connell R; Girgis A; Gebski VJ; Asher R; Mihalopoulos C; Bell ML; Zola KG; Beith J; Thewes B
    J Clin Oncol; 2017 Dec; 35(36):4066-4077. PubMed ID: 29095681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mindfulness-based cognitive therapy for Fear of Recurrence in Ovarian Cancer Survivors (FROCS): a single-arm, open-label, pilot study.
    Cohen PA; Musiello T; Jeffares S; Bennett K
    Support Care Cancer; 2022 Mar; 30(3):2317-2325. PubMed ID: 34727225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.